ACXPVSBTAI• 6 Months (Normalized)
ACXP vs BTAI (Acurx Pharmaceuticals Inc. vs BioXcel Therapeutics Inc.)
Showing Closing Date Range from Mar, 15 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ACXP Performance $1.4
-70.89%
Acurx Pharmaceuticals Inc.
Normalized Baseline0.00%
BTAI Performance $0.05
-96.69%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin ACXP LEADS
+25.8%
ACXP outperforming by 25.80%
ACXPBTAI
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ACXP BTAI
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(125 dates)
| Date | ACXP Price | ACXP Gain (%) | BTAI Price | BTAI Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $1.40 | -70.89% | $0.05 | -96.69% | +25.80% |
| Sep 10, 2026 | $1.40 | -70.89% | $0.05 | -96.75% | +25.86% |
| Sep 09, 2026 | $1.41 | -70.69% | $0.05 | -96.95% | +26.26% |
| Sep 08, 2026 | $1.43 | -70.27% | $0.04 | -97.21% | +26.94% |
| Sep 04, 2026 | $1.42 | -70.48% | $0.07 | -95.20% | +24.72% |
| Sep 03, 2026 | $1.40 | -70.89% | $0.12 | -92.34% | +21.45% |
| Sep 02, 2026 | $1.43 | -70.27% | $0.11 | -93.05% | +22.78% |
| Sep 01, 2026 | $1.40 | -70.89% | $0.14 | -91.10% | +20.21% |
| Aug 31, 2026 | $1.45 | -69.85% | $0.16 | -89.42% | +19.57% |
| Aug 28, 2026 | $1.44 | -70.06% | $0.18 | -88.25% | +18.19% |
| Aug 27, 2026 | $1.46 | -69.65% | $0.72 | -53.31% | -16.34% |
| Aug 26, 2026 | $1.43 | -70.27% | $0.78 | -49.35% | -20.92% |
| Aug 25, 2026 | $1.41 | -70.69% | $0.74 | -51.82% | -18.87% |
| Aug 24, 2026 | $1.40 | -70.89% | $0.76 | -50.58% | -20.31% |
| Aug 21, 2026 | $1.47 | -69.44% | $0.80 | -47.79% | -21.65% |
Page 1 of 9